Hemostatic Management of Patients undergoing Ear-Nose-Throat-Surgery

被引：3

作者：

Thiele, T. ^{[1
]}

Kaftan, H. ^{[2
]}

Hosemann, W. ^{[2
]}

Greinacher, A. ^{[1
]}

机构：

[1] Univ Med Greifswald, Abt Transfus Med, Inst Immunol & Transfus Med, D-17487 Greifswald, Germany

[2] Univ Med Greifswald, Klin & Poliklin Hals Nasen Ohrenkrankheiten Kopf, D-17487 Greifswald, Germany

来源：

LARYNGO-RHINO-OTOLOGIE | 2015年 / 94卷

关键词：

Antikoagulation; Thrombozytenaggregationshemmung; Thromboseprophylaxe; Blutungsrisiko; Thromboserisiko; anticoagulation; platelet inhibition; thromboprophylaxis; bleeding risk; thrombosis risk; BRIDGING ANTIPLATELET THERAPY; VENOUS THROMBOEMBOLISM; PERIOPERATIVE MANAGEMENT; ELUTING STENTS; NECK-CANCER; BLEEDING COMPLICATIONS; THROMBOPLASTIN TIME; OTOLARYNGOLOGY-HEAD; PROTHROMBIN TIME; URGENT SURGERY;

D O I：

10.1055/s-0034-1396872

中图分类号：

R76 [耳鼻咽喉科学];

学科分类号：

100213 ;

摘要：

Zusammenfassung Das perioperative Hamostasemanagement gewinnt auch in der Otorhinolaryngologie zunehmend an Bedeutung. Die vorliegende ubersichtsarbeit fasst den aktuellen Stand der Literatur zusammen und erlautert das perioperative Hamostasemanagement. Mit Bezug auf die HNO-Heilkunde werden die allgemeinen Prinzipien der Risikobewertung, Thromboseprophylaxe, und der uberbruckung der Antikoagulation erlautert. Abstract Perioperative hemostatic management is increasingly important in Otolaryngology. This review summarizes the key elements of perioperative risk stratification, thromboprophylaxis, and therapies for bridging of antithrombotic treatment. It gives a practical advise based on the current literature with an emphasis for patients undergoing ear-nose-throat surgery.

引用

页码：S143 / S152

页数：10

共 64 条

[1] Bleeding complications in patients with coronary stents during non-cardiac surgery [J].

Albaladejo, Pierre ;

Charbonneau, Helene ;

Samama, Charles-Marc ;

Collet, Jean-Philippe ;

Marret, Emmanuel ;

Piriou, Vincent ;

Genty, Celine ;

Bosson, Jean Luc .

THROMBOSIS RESEARCH, 2014, 134 (02) :268-272

[2] Bridging Antiplatelet Therapy With Cangrelor in Patients Undergoing Cardiac Surgery A Randomized Controlled Trial [J].

Angiolillo, Dominick J. ;

Firstenberg, Michael S. ;

Price, Matthew J. ;

Tummala, Pradyumna E. ;

Hutyra, Martin ;

Welsby, Ian J. ;

Voeltz, Michele D. ;

Chandna, Harish ;

Ramaiah, Chandrashekhar ;

Brtko, Miroslav ;

Cannon, Louis ;

Dyke, Cornelius ;

Liu, Tiepu ;

Montalescot, Gilles ;

Manoukian, Steven V. ;

Prats, Jayne ;

Topol, Eric J. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (03) :265-274

[3]

[Anonymous], GTH ANN 7 2013

[4]

[Anonymous], AWMF LEITLINIE PROPH

[5]

[Anonymous], CHEST S

[6]

[Anonymous], J EUR ACAD DERMATOL

[7]

[Anonymous], INTERNIST BERL

[8]

[Anonymous], CHEST S

[9] The need for routine pre-operative coagulation screening tests (prothrombin time PT/partial thromboplastin time PTT) for healthy children undergoing elective tonsillectomy and/or adenoidectomy [J].

Asaf, T ;

Reuveni, H ;

Yermiahu, T ;

Leiberman, A ;

Gurman, G ;

Porat, A ;

Schlaeffer, P ;

Shifra, S ;

Kapelushnik, J .

INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2001, 61 (03) :217-222

[10] Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry [J].

Beyer-Westendorf, Jan ;

Foerster, Kati ;

Pannach, Sven ;

Ebertz, Franziska ;

Gelbricht, Vera ;

Thieme, Christoph ;

Michalski, Franziska ;

Koehler, Christina ;

Werth, Sebastian ;

Sahin, Kurtulus ;

Tittl, Luise ;

Haensel, Ulrike ;

Weiss, Norbert .

BLOOD, 2014, 124 (06) :955-962

← 1 2 3 4 5 6 7 →